The MIND-BC Study: MIND Diet for Breast Cancer Cognition
MIND-BC
2 other identifiers
interventional
200
1 country
1
Brief Summary
This fully, powered efficacy RCT, the MIND diet for Breast Cancer Cognition (MIND-BC), will evaluate the MIND diet in a rigorous, highly controlled academic cancer center. We will recruit breast cancer survivors reporting CRCI with a MIND diet score \< 8, based on a previously devised 14-item diet questionnaire designed to detect inadequate diet with respect to brain health (scores range from 0 to 14, with lower scores indicating a less adequate diet).14 Breast cancer survivors will have recently completed adjuvant treatment (i.e., 6 months to three years previously), to ensure that perceived cognitive impairment is likely chronic and due to cancer. To achieve maximal effect, the study consists of two 12-week phases 1) intervention phase, 2) maintenance phase.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Jul 2025
Typical duration for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2025
CompletedFirst Posted
Study publicly available on registry
June 13, 2025
CompletedStudy Start
First participant enrolled
July 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2030
February 5, 2026
February 1, 2026
3.6 years
May 28, 2025
February 3, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Efficacy of the MIND diet: Self-reported cognition
The Functional Assessment of Cancer Therapy - General (FACT-G) will be used to determine self-reported cognition.
At 12 weeks and 3 months
Secondary Outcomes (3)
Efficacy of the MIND diet: Fatigue
At 12 weeks and 3 months
Efficacy of the MIND diet: Quality of life (QOL) and mood
At 12 weeks and 3 months
Efficacy of the MIND diet: Objective cognition
At Baseline, 12 weeks, and 3 months
Study Arms (2)
MIND Diet Arm
EXPERIMENTALParticipants (N=200) will be randomized 1:1 to a 12-week intervention phase. The MIND diet arm will be asked to participate in weekly "check-in" sessions with a diet coach supervised by a registered dietitian. To evaluate the longer-term effects of the MIND diet as a part of lifestyle change, we will also conduct a 3-month follow-up assessment.
Usual Diet Arm
ACTIVE COMPARATORParticipants (N=200) will be randomized 1:1 to a 12-week intervention phase. The usual diet participants will be provided with weekly grocery gift cards to purchase foods that follow their "usual" diet. Usual diet participants will also conduct a 3-month follow-up assessment.
Interventions
a combination of the Mediterranean and DASH diets emphasizing consumption of high-nutrient, plant-based foods such as green leafy vegetables, nuts, berries, fish, and olive oil while limiting intake of foods high in saturated fat, pre-processed snacks, sugar, red and processed meat.
Check-in sessions for the usual diet arm will focus on general health (e.g., healthy hair, skin, eyesight). None of the topics will include dietary information for the usual diet arm.
Eligibility Criteria
You may qualify if:
- Previously diagnosed with stage I-III breast cancer.
- Able to speak and read English.
- Able to consume foods orally.
- \>18 years of age.
- Able to provide informed consent.
- Have no documented or observable psychiatric or neurological disorder that would interfere with study participation (e.g., schizophrenia).
- Report 'somewhat' to 'very much' cognitive impairment in the past week (i.e., a score ≥ 2 on a 0-4 scale) that they attribute to cancer or its treatment.
- Report a MIND diet score \< 10 (range 0 to 14, higher score equates to higher diet quality).
- Willing to consume the MIND diet.
- Completed adjuvant treatment 6 months to three years previously.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moffitt Cancer Center
Tampa, Florida, 33612, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvia Crowder
Moffitt Cancer Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2025
First Posted
June 13, 2025
Study Start
July 9, 2025
Primary Completion (Estimated)
March 1, 2029
Study Completion (Estimated)
March 1, 2030
Last Updated
February 5, 2026
Record last verified: 2026-02